Clinical reasoning before prescribing

• Duration - is this <3 weeks (acute, usually post-viral), 3-8 weeks (subacute), or >8 weeks (chronic)? This changes the workup.
• Red flags for TB - fever, night sweats, weight loss, hemoptysis, TB contact history. In a young postpartum woman this must be actively excluded (sputum AFB/CXR) before symptomatic treatment, especially if cough has lasted beyond 2-3 weeks - do not just treat symptomatically and miss this.
• Associated allergic symptoms (nasal congestion, throat clearing, itchy eyes) → favors postnasal drip.
• Heartburn, worse when lying flat, sour taste → favors GERD.
• Nocturnal wheeze/dyspnea, history of atopy → favors cough-variant asthma.
• Any ACE-inhibitor or other new drug use (unlikely here but always check).
• Smoking/passive smoke exposure.

Breastfeeding-safe symptomatic options

• Postnasal drip / allergic cause: A second-generation, non-sedating antihistamine such as cetirizine or loratadine is preferred over first-generation agents (chlorpheniramine) for a nursing mother - minimal transfer into milk and no significant infant sedation reported. A nasal saline irrigation and, if allergic rhinitis is likely, an intranasal corticosteroid (e.g., fluticasone/mometasone) are safe adjuncts with negligible systemic/milk levels.
• Avoid oral decongestants (pseudoephedrine) - they can reduce milk supply and are best avoided in breastfeeding women.
• Avoid codeine and codeine-containing cough syrups entirely - the FDA specifically restricts/contraindicates codeine in breastfeeding women because of the risk of neonatal opioid toxicity, especially in CYP2D6 ultra-rapid metabolizers (Rosen's Emergency Medicine; Miller's Anesthesia).
• Dextromethorphan in standard OTC doses is generally considered compatible with breastfeeding (low milk transfer) if a dry-cough suppressant is needed for symptom relief, though evidence is limited - use the lowest effective dose for the shortest time.
• Honey/warm fluids/steam inhalation are safe, simple adjuncts.
• If GERD is suspected: a PPI such as omeprazole is considered compatible with breastfeeding.
• Antibiotics are not indicated unless there is evidence of bacterial infection (purulent sputum, fever, focal consolidation on exam/CXR) - this presentation (scant morning sputum, otherwise dry cough) does not suggest bacterial bronchitis or pneumonia.

Suggested approach

1. Take a focused history (duration, allergy symptoms, reflux symptoms, TB red flags, smoking exposure) and examine chest/ENT.
2. If cough is subacute/chronic (>3 weeks) or any red flag present → get a chest X-ray and, if endemic-TB-risk factors exist, sputum evaluation before symptomatic treatment.
3. If none of the above and pattern fits allergic postnasal drip: start cetirizine 10 mg OD + saline nasal wash ± intranasal steroid for 1-2 weeks and reassess.
4. If no improvement, evaluate for cough-variant asthma (trial of inhaled bronchodilator/spirometry) or GERD (trial of PPI + lifestyle measures - avoid late meals, elevate head of bed).
5. Reassess in 1-2 weeks; if cough persists beyond this empirical trial, refer for CXR/spirometry/ENT evaluation as per the sequential chronic-cough algorithm.

If it's allergic rhinitis (postnasal drip driving the cough)

Breastfeeding-safe pharmacotherapy, first-line

• Fluticasone propionate or mometasone nasal spray, once or twice daily.
• Minimal systemic absorption, so milk transfer is negligible - generally considered compatible with breastfeeding (unlike systemic/oral corticosteroids, which are "probably compatible but not recommended with breastfeeding" per Rosen's Emergency Medicine due to potential to interfere with lactation - so keep her on the topical/intranasal form, not oral steroids).
• This is more effective than oral antihistamines alone for allergic rhinitis (Goldman-Cecil Medicine).

• Cetirizine 10 mg once daily or loratadine 10 mg once daily.
• Both are non-sedating, have negligible entry into breast milk at these doses, and are the preferred antihistamines when treating a nursing or pregnant woman over first-generation agents like chlorpheniramine/diphenhydramine (Creasy & Resnik's Maternal-Fetal Medicine; Rosen's Emergency Medicine).
• Avoid the combination product with pseudoephedrine (e.g., Zyrtec-D) - the decongestant component can suppress milk supply.

• Saline nasal irrigation - safe, no restriction, can be used liberally.
• If nasal itching/sneezing is prominent and not controlled by the above, an intranasal antihistamine (azelastine) can be added - evidence shows it's actually superior to oral antihistamine as add-on therapy to intranasal steroid (Goldman-Cecil Medicine, Grade A reference).

What to avoid

• Oral decongestants (pseudoephedrine, phenylephrine) - risk of reducing milk supply.
• Codeine-containing cough preparations - contraindicated in breastfeeding (FDA).
• Long-term first-generation antihistamines - sedating, anticholinergic, and cross into milk more than second-generation agents.
• Oral systemic corticosteroids as routine therapy - reserve for severe refractory cases only, and only briefly.

Practical regimen

• Intranasal corticosteroid spray, 1-2 sprays each nostril once daily, ongoing.
• Cetirizine 10 mg or loratadine 10 mg once daily.
• Saline nasal rinse as needed.
• Reassess in 2 weeks - if cough resolves, continue for a full allergy-treatment course (typically several weeks) and consider identifying/avoiding the trigger (dust, pets, seasonal pollen); if no improvement, reconsider GERD or cough-variant asthma as the driver, or refer to ENT/allergy for skin testing.

Management Plan - Chronic Cough (Allergic Rhinitis / Upper Airway Cough Syndrome) in a Breastfeeding Mother

1. Initial Assessment (before starting treatment)

• Confirm duration of cough (acute <3 wk / subacute 3-8 wk / chronic >8 wk)
• Screen and exclude red flags: fever, night sweats, weight loss, hemoptysis, TB contact - if present or cough >2-3 weeks, get CXR ± sputum evaluation before symptomatic treatment
• Look for allergic triggers: nasal itching/congestion, sneezing, throat clearing, seasonal/dust/pet exposure
• Rule out competing causes: GERD (heartburn, worse lying flat), cough-variant asthma (nocturnal wheeze/dyspnea), ACE-inhibitor use, smoking exposure

2. Non-pharmacological Measures

• Allergen avoidance: dust mites, pet dander, pollen, smoke exposure
• Saline nasal irrigation/rinse, 1-2 times daily
• Steam inhalation, warm fluids, honey for symptomatic soothing
• Maintain adequate hydration

3. Pharmacological Management (breastfeeding-compatible)

Avoid

• Oral decongestants (pseudoephedrine, phenylephrine) - can reduce milk supply
• Codeine-containing cough syrups - contraindicated in breastfeeding (FDA warning: neonatal opioid toxicity risk)
• Routine oral/systemic corticosteroids - reserve for severe refractory cases only, short course
• First-generation sedating antihistamines as long-term therapy

4. Follow-up

• Reassess at 2 weeks
• If cough resolves: continue intranasal steroid + antihistamine for a full course (several weeks), address ongoing allergen exposure
• If no improvement: reconsider GERD (trial PPI - omeprazole, safe in lactation) or cough-variant asthma (inhaled bronchodilator trial, spirometry)
• If still unresponsive: refer to ENT/allergy for skin testing, or pulmonology for CXR/spirometry per chronic-cough algorithm

5. Patient Counseling

• Continue breastfeeding as normal - all recommended drugs above are considered compatible with lactation at these doses
• Expect gradual improvement over 1-2 weeks with intranasal steroid; it is not an immediate-relief medication
• Return earlier if fever, hemoptysis, weight loss, or worsening breathlessness develop

Management Plan - Allergic Bronchitis (Cough-Variant Asthma / Allergic Airway Disease)

1. Confirm the Diagnosis

• Spirometry with bronchodilator reversibility, or peak flow variability, to document airflow obstruction/hyperreactivity
• If spirometry normal but suspicion remains high: methacholine challenge or empirical bronchodilator trial
• Check for eosinophilia (peripheral blood or induced sputum) - supports eosinophilic/allergic bronchitis
• Chest X-ray if not already done, to exclude other causes
• Continue to exclude red flags (TB, hemoptysis, weight loss) as before

2. Non-pharmacological

• Strict allergen avoidance (dust, pollen, pet dander, smoke, cold air, strong odors)
• Continue nasal saline irrigation for the upper airway component
• Adequate hydration, avoid known triggers

3. Pharmacological Management (breastfeeding-compatible)

Avoid

• Oral/systemic corticosteroids for routine control - reserve strictly for acute severe exacerbations, short course only
• Codeine-based antitussives - contraindicated in breastfeeding
• Oral decongestants (pseudoephedrine) - may reduce milk supply
• Unnecessary antibiotics - no role unless secondary bacterial infection is evident

4. Monitoring and Follow-up

• Reassess symptoms and peak flow/spirometry at 2-4 weeks
• Step up therapy (add LABA, or short oral steroid course) if poorly controlled; step down once stable for 3 months
• Watch for signs needing urgent care: increasing breathlessness, use of accessory muscles, inability to complete sentences, cyanosis - refer to emergency care immediately
• Continue breastfeeding throughout treatment - inhaled/topical agents at these doses are not expected to pose risk to the infant

5. Patient Counseling

• Explain that inhalers act locally in the airway with very little entering the bloodstream or breast milk, unlike oral tablets
• Correct inhaler technique is essential for efficacy - consider spacer device
• Identify and avoid personal triggers (document a symptom diary if trigger unclear)
• Return early if fever, hemoptysis, or significant weight loss develop (needs re-evaluation for TB or other pathology)